People · Operator

Rebecca Jane Rone

Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology

1
Companies
3
Filings
$9.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Dermelle, LLCBiotechnologySeries A$9.4M$89.6M2013
Operator network

Rebecca Jane Rone at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Anna Magdalena Lundvall · 2 companies · 1 sharedAnna Magdalena Lu…Anthony Nathaniel Harris · 2 companies · 1 sharedAnthony Nathaniel…David Alan Grant · 2 companies · 1 sharedDavid Alan GrantDavid Burton Keller · 2 companies · 1 sharedDavid Burton Kell…Luis Raul Jimenez · 2 companies · 1 sharedLuis Raul JimenezRobert J Brooks · 2 companies · 1 sharedRobert J BrooksCharles Alan Weatherstone · 1 companies · 1 sharedCharles Alan Weat…Dale Paul DeVore · 1 companies · 1 sharedDale Paul DeVoreGuy Francois Bouchard · 1 companies · 1 sharedGuy Francois Bouc…Rebecca Jane Rone-McCrate · 1 companies · 1 sharedRebecca Jane Rone…Ronald No Middle Name Bassuner · 1 companies · 1 sharedRonald No Middle …Sheila Ann Grant · 1 companies · 1 sharedSheila Ann GrantDermelle, LLC · $9.4M raisedDermelle, LLCRebecca Jane RoneRR
Rebecca Jane Rone Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Rebecca Jane Rone on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Anthony Nathaniel Harris12
David Burton Keller12
Luis Raul Jimenez12
David Alan Grant12
Robert J Brooks12
Anna Magdalena Lundvall12
Rebecca Jane Rone-McCrate11
Ronald No Middle Name Bassuner11
Sheila Ann Grant11
Dale Paul DeVore11
Charles Alan Weatherstone11
Guy Francois Bouchard11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.